CONFIDENTIAL
L&T Finance Limited
(formerly known as L&T Finance Holdings Limited)
Information required to be disclosed under Regulation 14 of Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity)
Regulations, 2021, as amended from time to time.
A. | Relevant disclosures in accordance with 'Indian Accounting Standard 102- | Refer | Note | No. | 1 | of |
Share based payment' as notified by the Ministry of Corporate Affairs including | Annexure A | |||||
the 'Guidance note on accounting for employee share based payments'. | ||||||
B. | Diluted EPS on issue of shares pursuant to all the schemes covered under the | Refer | Note | No. | 2 | of |
regulations shall be disclosed in accordance with 'Indian Accounting Standard | Annexure A | |||||
33 - Earning per share' as notified by the Ministry of Corporate Affairs | ||||||
- Details related to ESOS
Sr. | Particulars | ESOP Scheme 2010 | ESOP Scheme 2013 |
No. | |||
- A description of each ESOP that existed at any time during the year, including the general terms and conditions of each ESOP, including -
a) | Date | of | November 29, 2010 | April 4, 2014 | ||
shareholders' approval | ||||||
b) | Total | number of | options | 3,42,95,232 | 5,15,84,661 | |
approved under ESOP | ||||||
c) | Vesting requirements | Vesting will commence one year | Vesting will commence two years or | |||
after the date of grant at the rates | one year after the date of grant and | |||||
given below or at such other rates as | may extend up to four years from the | |||||
may be fixed by the Nomination & | date of grant as the case may be. The | |||||
Remuneration Committee and may | percentage of vesting each year shall | |||||
extend upto four years from the date | be at the rates decided by the | |||||
of grant, unless otherwise varied in | Management. | |||||
accordance with the Rules. | ||||||
d) | Exercise price or pricing | The exercise price for the purposes of the grant of Stock Options will be as per | ||||
formula | terms & conditions decided by the Board and / or Nomination & Remuneration | |||||
Committee at the time of respective grant of Stock Options, but at a price not | ||||||
below the face value of the equity share and not exceeding the market price as | ||||||
per the SEBI Regulations. | ||||||
e) | Maximum term | of | The Exercise Period would be seven | Eight years (96 months) from the date | ||
options granted | years (84 months) from the date of | of grant or Three years (36 months) | ||||
grant or 3 years (36 months) from the | from the date of retirement/death | |||||
date of retirement / death, whichever | whichever is earlier. | |||||
is earlier. | ||||||
f) | Source of shares | Primary | Primary | |||
(primary, secondary or | ||||||
combination) | ||||||
CONFIDENTIAL
g) Variation in terms of options
N.A.
N.A.
- Method used to account for ESOP - Intrinsic or fair value.
Fair Value
- Option movement during the year (For each ESOS):
Particulars | ESOP Scheme 2010 | ESOP Scheme 2013 | ||||
Number of options outstanding at the beginning of the | 5,63,750 | 2,75,38,744 | ||||
period | ||||||
Number of options granted during the year | -- | 67,41,444 | ||||
Number of options forfeited / lapsed during the year* | -- | 32,49,742 | ||||
Number of options vested during the year | 78,750 | 40,28,642 | ||||
Number of options exercised during the year | 4,98,750 | 87,70,443 | ||||
Number of shares arising as a result of exercise of options | 4,98,750 | 87,70,443 | ||||
Money realized by exercise of options (₹), if scheme is | 1,75,02,187.50 | 40,75,92,940.98 | ||||
implemented directly by the Company | ||||||
Loan repaid by the Trust during the year from exercise | N.A. | N.A. | ||||
price received | ||||||
Number of options outstanding at the end of | 65,000 | 2,22,60,003 | ||||
the year | ||||||
Number of options exercisable at the end of the year | 65,000 | 1,13,32,467 | ||||
(v) Weighted-average exercise prices and weighted-average fair | Weighted-average exercise prices - ₹ 10 | |||||
values of options shall be disclosed separately for options | ||||||
whose exercise price either equals or exceeds or is less than | Weighted-average fair values - ₹ 118.74 | |||||
the market price of the stock. | ||||||
(vi) Employee wise details (name of employee, designation, | ||||||
number of options granted during the year, exercise price) of | ||||||
options granted to - | ||||||
a) Key Managerial Personnel and Senior managerial | Please refer to Annexure B | |||||
personnel; | ||||||
b) | any other employee who receives a grant in any one | None | ||||
year of option amounting to 5% or more of option | ||||||
granted during that year: and | ||||||
c) | identified employees who were granted option, during any | None | ||||
one year, equal to or exceeding 1% of the issued capital | ||||||
(excluding outstanding warrants and conversions) of the | ||||||
Company at the time of grant. |
*Options lapsed during the year on account of resignation of the employee
- A description of the method and significant assumptions used during the year to estimate the fair value of options including the following information:
Weighted | average | exercise | price | - | |
₹ | 10, | Weighted | average share | price | - |
₹ | 131.38, Expected volatility - 36.53% Calculated |
CONFIDENTIAL
a) the weighted-average values of share price, exercise | by using the closing market prices of the | |
price, expected volatility, expected option life, expected | Company's Shares during the last one year. | |
dividends, the risk-free interest rate and any other inputs | Expected life - Full life of the option is the period | |
to the model; | up to which it can be exercised. | |
Expected dividends - Yield has been calculated on | ||
the basis of dividend yield of the financial year. | ||
Risk-free interest rate - This is the rate offered in | ||
the market with virtually zero risk. Normally the | ||
yield of Government backed securities with | ||
maturity similar to that of the option is taken into | ||
consideration. | ||
b) the method used and the assumptions made to | As decided by the Management in case of | |
incorporate the effects of expected early exercise; | Retirement and Death of an employee. | |
c) how expected volatility was determined, including an | Expected volatility is based on the historical | |
explanation of the extent to which expected volatility was | volatility of the Company shares price applicable to | |
based on historical volatility; and | the expected life of each option. | |
d) whether and how any other features of the option grant | The price of underlying shares in market at the time | |
were incorporated into the measurement of fair value, | of option grant - closing market price, on previous | |
such as a market condition. | trading day on which the options are granted, on | |
the Stock Exchange where the volume of shares | ||
traded is more. | ||
Disclosures in respect of grants made in three years prior to | ||
IPO under each ESOP | ||
Until all options granted in the three years prior to the IPO have been | Not Applicable | |
exercised or have lapsed, disclosures of the information specified | ||
above in respect of such options shall also be made. |
CONFIDENTIAL
Annexure A
1. Stock option scheme
- The Company has formulated Employee Stock Option Schemes 2010 (ESOP Scheme- 2010) and 2013 (ESOP Scheme 2013). The grant of options to the employees under the stock option schemes is on the basis of their performance and other eligibility criteria. The options allotted under the scheme 2010 are vested over a period of four years in the ratio of 15%, 20%, 30% and 35% respectively from the end of 12 months from the date of grant, subject to the discretion of the management and fulfillment of certain conditions. The options granted under the scheme 2013 are vested in a graded manner over a period of four years with 0%, 33%, 33% and 34% of grants vesting each year, commencing from the end of 24 months from the date of grant or w.e.f. July 10, 2019 vested in a graded manner over a period of four years with 25%, 25%, 25% and 25% of grants vesting each year, commencing from the end of 12 months from the date of grant.
- Options allotted under scheme 2010 can be exercised anytime within a period of 7 years from the date of grant and would be settled by way of equity. The option granted under scheme 2013 can be exercised anytime within a period of 8 years from the date of grant. Management has discretion to modify the exercise period.
- The option granted under scheme 2010 is at exercise price of ₹ 44.20. The option granted under scheme 2013 can be exercised either at market price which was the last closing price on National stock exchange preceding the date of grant or w.e.f. July 10, 2019 ₹ 10 respectively.
- During the year ended March 31, 2024, 498,750 and 87,70,443 options were allotted under the scheme 2010 and 2013 respectively.
- The details of the grants are summarised below:
Sr. | Particulars | ESOP Scheme 2010 | ESOP Scheme 2013 | ||
No. | 2023-24 | 2022-23 | 2023-24 | 2022-23 | |
1 | Options granted and outstanding at the | 563,750 | 9,48,250 | 2,75,38,744 | 2,16,22,255 |
beginning of the year | |||||
2 | Options granted during the year | 0 | 67,41,444 | ||
3 | Options cancelled/ lapsed during the | 0 | 1,88,000 | 32,49,742 | 80,02,047 |
year | |||||
4 | Options exercised during the year | 498,750 | 1,96,500 | 87,70,443 | 54,39,129 |
5 | Options granted and outstanding at the | ||||
end of the year of which - | |||||
- Options vested | 65,000 | 4,85,000 | 1,13,32,467 | 1,83,45,892 | |
- Options yet to vest | 0 | 78,750 | 1,09,27,536 | 91,92,852 | |
6 | Weighted average remaining | 0.75 | 2.81 | 4.18 | 4.78 |
contractual life of options (in years) | |||||
f) During the year, the Company has debited to the Statement of Profit and Loss
- 38.01 crore (Previous year ₹ 25.74 Crore) {net of recovery/(payment) from/to its subsidiary companies during the year ₹ (0.16) Crore (Previous year: ₹ (0.09) Crore)} towards the stock options granted to their employees, pursuant to the employee stock option schemes.
CONFIDENTIAL
-
Weighted average fair values of options granted during the year is ₹ 118.74 Crore
(previous year: ₹ 69.48) per options. - The Fair value has been calculated using the Black-Scholes Option Pricing Model and the significant assumptions and inputs to estimate the fair value of options granted during the year are as follows:
Sr. No. | Particulars | 2023-24 | 2022-23 | ||
a) | Weighted average risk-free interest rate | 7.20% | 6.65% | ||
b) | Weighted average expected life of | 2.77 years | 2.75 years | ||
options | |||||
c) | Weighted | average | expected | 36.53% | 39.16% |
volatility | |||||
d) | Weighted | average | expected | ₹ 5.54 per option | ₹ 2.66 per option |
dividends | |||||
e) | Weighted average share price | ₹ 131.38 per option | ₹ 79.87 per option | ||
f) | Weighted average exercise price | ₹ 10.00 per share | ₹ 10.00 per share | ||
g) | Method used to determine expected | Expected volatility is based on the historical volatility of the | |||
volatility | Company shares price applicable to the expected life of | ||||
each option. | |||||
2. Basic and Diluted Earnings per share [EPS] computed in accordance with Indian
Accounting Standard (Ind AS) 33 "Earnings per Share'':
Particulars | 2023-24 | 2022-23 | |
Basic | |||
Profit after tax (₹ Crore) | A | 2,286.23 | 1,919.87 |
Weighted average number of equity shares outstanding | B | 2,48,43,28,659 | 2,47,68,83,662 |
Basic EPS before and after extraordinary items (₹) | A/B | 9.20 | 7.75 |
Diluted | |||
Profit after tax (₹ Crore) | A | 2,286.23 | 1,919.87 |
Weighted average number of equity shares outstanding | B | 2,48,43,28,659 | 2,47,68,83,662 |
Add: Weighted average no. of potential equity shares on | 99,47,132 | 83,44,407 | |
account of employee stock options | C | ||
Weighted average number of shares outstanding for | D=B+C | 2,49,42,75,791 | 2,48,52,28,068 |
diluted EPS | |||
Diluted EPS before and after extraordinary items (₹) | A/D | 9.17 | 7.73 |
Face value of shares (₹) | 10.00 | 10.00 | |
CONFIDENTIAL
Annexure B
Details of options granted to Key Managerial Personnel ("KMP") and
Senior Management Personnel ("SMP") during FY2023-24
Sr. No. | Names of KMP/SMP | Designation | Units granted |
1 | Sudipta Roy | Managing Director &CEO | 6,00,000 |
2 | Sachinn Joshi | Chief Financial Officer | 4,74,294 |
3 | Apurva Rathod | Company Secretary | 2,12,008 |
4 | Raju Dodti | Chief Operating Officer | 4,74,294 |
5 | Abhishek Animesh | Chief Executive - SME | 4,74,294 |
Sharma | Finance | ||
6 | Sonia Krishnankutty | Chief Executive - Rural | 2,91,511 |
Business Finance | |||
7 | Asheesh Goel | Chief Executive Officer - | 1,32,505 |
Farmer Finance | |||
8 | Rupa Rege Nitsure(1) | Chief Economist | 1,59,006 |
- Ceased to be a SMP w.e.f. April 1, 2024 pursuant to superannuation. Hence, grant lapses post her superannuation and reverts back to the company pool as per policy.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
L&T Finance Holdings Limited published this content on 29 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 May 2024 12:35:10 UTC.